For UK Healthcare Professionals
Important notice: this area of the site is intended for UK healthcare professionals. By entering this site, you are confirming that you are a UK healthcare professional.
This area of the site is intended for members of the UK public, patients and their carers.
ProceedThis link will take you to a non-Lupin UK website. Lupin does not recommend, endorse or accept liability for sites controlled by third-parties.
Lupin collaborates with HCPs and patient groups to help address challenges of supply, access and reducing costs to the NHS and helping to deliver improved patient outcomes.
In addition, Lupin has worked with organisations such as the NHS, NICE and MHRA to ensure medicines are brought to patients as quickly as possible.
Lupin are a committed partner to the NHS.
The Department of Health and Social Care defines Joint Working as “Situations where, for the benefit of patients, one or more pharmaceutical companies, the NHS and others (e.g. Patient Groups) pool skills, experience and/or resources for the joint development and implementation of patient-centred projects and share a commitment to successful delivery”.
Lupin are fully committed to partnering with the NHS to develop new services and pathways that better serve the needs of patients.
Lupin proudly supports healthcare organisations and patient organisations with medical and educational activities to enhance and maintain patient care and benefit research.
Requests for grants/donations must be for a specific activity or event. They must be submitted independently of Lupin, and there can be no benefit to Lupin as a result.
To submit a grant/donation request please send to UKMedical@lupin.com.
To submit a sponsorship request for a conference or an educational meeting/course, please send to UKMedical@lupin.com
We value the work of patient groups and the important role they play in supporting patients whose lives are affected by various medical conditions/illnesses.
Lupin works with and supports patient organisations in order to understand the patient’s views of their condition. Providing accurate, useful information for the public and patients helps improve patient outcomes and/or patient experience with the care they receive.
Lupin ensures it acts with a high degree of integrity and transparency. As we adhere to the Association of the British Pharmaceutical Industry (ABPI) code of practice, we declare a list of patient organisations to which we provide financial support and/or significant non-financial support.
To ensure transparency of our partnerships with patient groups, we declare all funding which we provide.
Lupin is passionate about advancing health and addressing the unmet needs of patients. To do this, we must closely engage with healthcare organisations (HCOs) and Healthcare professionals (HCPs) for scientific expertise.
We provide payments and funding to HCPs for their time and expertise. We also provide funding to HCOs to support patient care or to benefit the NHS, and to organisations for research and development (R&D).
The pharmaceutical industry is committed to greater transparency of financial relationships with HCPs and HCOs.
We adhere to the Association of the British Pharmaceutical Industry (ABPI) code and disclose payments and benefits to HCPs and HCOs. Lupin discloses details of certain Transfer of Value (ToV) payments and benefits to individually named HCPs and HCOs on a publicly searchable database, Disclosure UK, which is hosted on the ABPI website.
For more information on studies with Lupin medicines, both worldwide and in the UK, please visit independent registries such as https://www.clinicaltrials.gov/ and https://eudract.ema.europa.eu/.
The HRA research summaries website also provides a comprehensive list of clinical research studies running in the UK.
If you would like to get in touch, please contact us by the following:
Email to: information@lupin.com or Customer Services on 01565 751378
